Condition
Pyruvate Dehydrogenase Complex Deficiency
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (1)
P 3 (1)
Trial Status
Unknown2
Recruiting1
Active Not Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06340685Phase 1RecruitingPrimary
Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency
NCT06931262UnknownPrimary
Expanded Access Treatment Protocol With DCA for Patients With PDCD
NCT02616484Phase 3Active Not RecruitingPrimary
Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:
NCT05257005UnknownPrimary
Natural History Study of Pyruvate Dehydrogenase Deficiency
NCT03734263Phase 2CompletedPrimary
Use of Phenylbutyrate Therapy for Patients With Pyruvate Dehydrogenase Complex Deficiency.
Showing all 5 trials